Cargando…

Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance

BACKGROUND: While mental comorbidity is considered common in multiple sclerosis (MS), its impact is poorly defined; methods are needed to support studies of mental comorbidity. We validated and applied administrative case definitions for any mental comorbidities in MS. METHODS: Using administrative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marrie, Ruth Ann, Fisk, John D, Yu, Bo Nancy, Leung, Stella, Elliott, Lawrence, Caetano, Patricia, Warren, Sharon, Evans, Charity, Wolfson, Christina, Svenson, Lawrence W, Tremlett, Helen, Blanchard, James F, Patten, Scott B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599013/ https://www.ncbi.nlm.nih.gov/pubmed/23388102 http://dx.doi.org/10.1186/1471-2377-13-16

Ejemplares similares

Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Differing trends in the incidence of vascular comorbidity in MS and the general population
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Differences in the burden of psychiatric comorbidity in MS vs the general population
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

Effect of comorbidity on mortality in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991–2010)
por: Kingwell, Elaine, et al.
Publicado: (2015)

Disease-modifying drugs for multiple sclerosis and subsequent health service use
por: Ng, Huah Shin, et al.
Publicado: (2021)

Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis
por: Zhang, Tingting, et al.
Publicado: (2016)

Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study
por: McKay, Kyla A, et al.
Publicado: (2016)

Etiology, effects and management of comorbidities in multiple sclerosis: recent advances
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival
por: Ng, Huah Shin, et al.
Publicado: (2022)

Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
por: Graf, Jonas, et al.
Publicado: (2023)

Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: A prospective multisite study
por: McKay, Kyla A., et al.
Publicado: (2015)

Sex and age differences in the Multiple Sclerosis prodrome
por: Yusuf, Fardowsa L. A., et al.
Publicado: (2022)

Persistence to disease-modifying therapies for multiple sclerosis in a Canadian cohort
por: Melesse, Dessalegn Y, et al.
Publicado: (2017)

Medication adherence in multiple sclerosis as a potential model for other chronic diseases: a population-based cohort study
por: Evans, Charity, et al.
Publicado: (2021)

Effect of adherence to the first-generation injectable immunomodulatory drugs on disability accumulation in multiple sclerosis: a longitudinal cohort study
por: Zhang, Tingting, et al.
Publicado: (2017)

Validation of an algorithm for identifying MS cases in administrative health claims datasets
por: Culpepper, William J., et al.
Publicado: (2019)

Peripartum depression in parents with multiple sclerosis and psychiatric disorders in children
por: Razaz, Neda, et al.
Publicado: (2016)

Emergency department use by persons with MS: A population-based descriptive study with a focus on infection-related visits
por: Graf, Jonas, et al.
Publicado: (2022)

Incidence and prevalence of multiple sclerosis in Europe: a systematic review
por: Kingwell, Elaine, et al.
Publicado: (2013)

The Barancik lecture: Comorbidity in multiple sclerosis—Looking backward, looking forward
por: Marrie, Ruth Ann
Publicado: (2023)

Polygenicity of Comorbid Depression in Multiple Sclerosis
por: Kowalec, Kaarina, et al.
Publicado: (2023)

Children and adolescents adjustment to parental multiple sclerosis: a systematic review
por: Razaz, Neda, et al.
Publicado: (2014)

Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data
por: Marrie, Ruth Ann, et al.
Publicado: (2017)

An integrated framework for the geographic surveillance of chronic disease
por: Yiannakoulias, Nikolaos, et al.
Publicado: (2009)

High prevalence of comorbidities at diagnosis in immigrants with multiple sclerosis
por: Rotstein, Dalia, et al.
Publicado: (2021)

The challenge of comorbidity in clinical trials for multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Administrative data for observational research in multiple sclerosis: Opportunities and challenges
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Using population-wide administrative and laboratory data to estimate type- and subtype-specific influenza vaccine effectiveness: a surveillance protocol
por: Scott, Allison Nicole, et al.
Publicado: (2019)

A population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada
por: McKay, Kyla, et al.
Publicado: (2017)

Recommendations for observational studies of comorbidity in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Association between disease-modifying therapies for multiple sclerosis and healthcare utilisation on a population level: a retrospective cohort study
por: Al-Sakran, Lina, et al.
Publicado: (2019)

Phenome-wide examination of comorbidity burden and multiple sclerosis disease severity
por: Zhang, Tingting, et al.
Publicado: (2020)

A population‐based study comparing multiple sclerosis clinic users and non‐users in British Columbia, Canada
por: McKay, K. A., et al.
Publicado: (2016)

Disease-Modifying Drug Uptake and Health Service Use in the Ageing MS Population
por: Ng, Huah Shin, et al.
Publicado: (2022)

Effects of Vascular Comorbidity on Cognition in Multiple Sclerosis Are Partially Mediated by Changes in Brain Structure
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

Identifying people with multiple sclerosis in the Canadian Primary Care Sentinel Surveillance Network
por: Marrie, Ruth Ann, et al.
Publicado: (2019)

Children of chronically ill parents: Relationship between parental multiple sclerosis and childhood developmental health
por: Razaz, Neda, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_117mj5dchu90k0oc0g40nro3d4